Related Experiment Video
Updated: Aug 14, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
[Plasma cell leukemia (IgG kappa) presenting bilateral neurosensory hearing loss and left sixth cranial nerve plasy]
S Aikawa1, K Morimoto, T Kumagai
1First Department of Internal Medicine, Nihon University School of Medicine.
Abstract:
A 30-year-old man who had been given a diagnosis of IgG-kappa multiple myeloma by another hospital and treated with melphalan, prednisone, and cyclophosphamide 6 months earlier, was admitted to our hospitaly in July 1994 because of progressively impaired hearing in both ears, vertigo, and worsening fatigue. Peripheral blood examination showed a white blood cell count 25,000/microliter, with 77.5% atypical plasma cells. Examination at the time of hospitalization also revealed retinal hemorrhages and serum hyperviscosity. The diagnosis was plasma cell leukemia with hyperviscosity syndrome. Subsequent treatment consisted of vincristine, doxorubicine, and prednisone and repeated plasmapheresis. This resulted in a partial response and a reduction of serum viscosity but no reversal of hearing loss. One month after admission, left sixth cranial nerve plasy was demonstrated. Cranial computed tomography studies disclosed a tumoral mass in the sphenoid sinus. The patient received local radiotherapy and intensive chemotherapy, but exhibited no notable alleviation of his cranial nerve palsy. He died of septicemia and progressive disease in August 1994. This case was rare in that it involved plasma cell leukemia and bilateral neurosensory hearing loss associated with serum hyperviscosity and sixth cranial nerve plasy due to plasmacytoma within the sphenoid sinus.
Insights
This rare case highlights plasma cell leukemia presenting with hearing loss and cranial nerve palsy. Early diagnosis and treatment are crucial for managing this aggressive hematologic malignancy.
Area of Science:
- Hematology
- Neurology
- Oncology
Background:
- A 30-year-old male diagnosed with IgG-kappa multiple myeloma previously received melphalan, prednisone, and cyclophosphamide.
- The patient presented with progressive bilateral hearing loss, vertigo, and fatigue.
Observation:
- Peripheral blood revealed a high white blood cell count with atypical plasma cells.
- Retinal hemorrhages and serum hyperviscosity were noted, leading to a diagnosis of plasma cell leukemia with hyperviscosity syndrome.
- A tumoral mass in the sphenoid sinus was identified, causing left sixth cranial nerve palsy.
Findings:
- Treatment with vincristine, doxorubicin, prednisone, and plasmapheresis achieved partial response and reduced serum viscosity but did not reverse hearing loss.
- The patient's cranial nerve palsy showed no significant improvement despite radiotherapy and intensive chemotherapy.
- The patient ultimately died of septicemia and progressive disease.
Implications:
- This case underscores the rare association of plasma cell leukemia with neurosensory hearing loss and cranial nerve palsy due to sphenoid sinus plasmacytoma.
- Highlights the complexity of managing advanced plasma cell disorders with multi-systemic involvement.
- Emphasizes the need for comprehensive evaluation in patients with multiple myeloma complications.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Cytotoxic Edema: Pathophysiology

